(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE

DB07211ExperimentalSmall molecule

(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE: Overview.

Formula / weight: C₁₈H₂₄ClN₃O₅S₂ · 461.983 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL391640PubChem10095865

Structure

InChIKeyYMJHMJLNQLVUAV-GHYUOPHCSA-NSMILESC[C@H](N1CC[C@H](NS(=O)(=O)\C=C(/C)C2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1

Targets

P00734F2 P00742F10

What you can answer from here — as of September 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account